GlassScriptPhysician profile
Sarah Blau
NPI 1417556606
$1,381.64
in general payments reported to CMS, 2019-2025
9 companies · $510 in 2025
The $510 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2022: $351 · 2023: $127 · 2024: $211 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.43 |
| Education | $107.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $662.63 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $219.92 | 2025 | Spy-Phi System, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Organogenesis INC. | $125.08 | 2025 | Puraply Wound Matrix |
| Medical Device Business Services, INC. | $107.69 | 2025 | |
| Haemonetics Corporation | $99.89 | 2022 | |
| Integra Lifesciences Corporation | $64.70 | 2021-2022 | |
| Atricure, INC. | $57.51 | 2025 | Atriclip Laa Exclusion System |
| Ethicon US, LLC | $24.48 | 2024 | Echelon Flex |
| Alexion Pharmaceuticals, INC. | $19.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Blau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.